147 related articles for article (PubMed ID: 34445732)
21. Neonatal infection of mice with lactate dehydrogenase-elevating virus results in suppression of humoral antiviral immune response but does not alter the course of viraemia or the polyclonal activation of B cells and immune complex formation.
Rowland RR; Even C; Anderson GW; Chen Z; Hu B; Plagemann PG
J Gen Virol; 1994 May; 75 ( Pt 5)():1071-81. PubMed ID: 8176369
[TBL] [Abstract][Full Text] [Related]
22. C58 and AKR mice of all ages develop motor neuron disease after lactate dehydrogenase-elevating virus infection but only if antiviral immune responses are blocked by chemical or genetic means or as a result of old age.
Anderson GW; Even C; Rowland RR; Palmer GA; Harty JT; Plagemann PG
J Neurovirol; 1995 Sep; 1(3-4):244-52. PubMed ID: 9222362
[TBL] [Abstract][Full Text] [Related]
23. Complement-mediated clearance of erythrocytes: mechanism and delineation of the regulatory roles of Crry and DAF. Decay-accelerating factor.
Molina H; Miwa T; Zhou L; Hilliard B; Mastellos D; Maldonado MA; Lambris JD; Song WC
Blood; 2002 Dec; 100(13):4544-9. PubMed ID: 12393518
[TBL] [Abstract][Full Text] [Related]
24. Changes in antibody specificities and cytokine release after infection with lactate dehydrogenase-elevating virus.
Aparicio JL; Saxena A; Coutelier JP; Van Snick J; Retegui LA
Int Immunopharmacol; 2013 Mar; 15(3):544-9. PubMed ID: 23391715
[TBL] [Abstract][Full Text] [Related]
25. Lactate dehydrogenase-elevating virus: an ideal persistent virus?
Plagemann PG; Rowland RR; Even C; Faaberg KS
Springer Semin Immunopathol; 1995; 17(2-3):167-86. PubMed ID: 8571167
[TBL] [Abstract][Full Text] [Related]
26. Replication competition between lactate dehydrogenase-elevating virus quasispecies in mice. Implications for quasispecies selection and evolution.
Plagemann PG; Chen Z; Li K
Arch Virol; 2001 Jul; 146(7):1283-96. PubMed ID: 11556706
[TBL] [Abstract][Full Text] [Related]
27. C5aR activation in the absence of C5a: A new disease mechanism of autoimmune hemolytic anemia in mice.
Syed SN; Rau E; Ziegelmann M; Sogkas G; Brüne B; Schmidt RE
Eur J Immunol; 2018 Apr; 48(4):696-704. PubMed ID: 29277896
[TBL] [Abstract][Full Text] [Related]
28. Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice.
Kumar V; Ali SR; Konrad S; Zwirner J; Verbeek JS; Schmidt RE; Gessner JE
J Clin Invest; 2006 Feb; 116(2):512-20. PubMed ID: 16453025
[TBL] [Abstract][Full Text] [Related]
29. Complexity of the single linear neutralization epitope of the mouse arterivirus lactate dehydrogenase-elevating virus.
Plagemann PG
Virology; 2001 Nov; 290(1):11-20. PubMed ID: 11882995
[TBL] [Abstract][Full Text] [Related]
30. Both FcgammaRIV and FcgammaRIII are essential receptors mediating type II and type III autoimmune responses via FcRgamma-LAT-dependent generation of C5a.
Syed SN; Konrad S; Wiege K; Nieswandt B; Nimmerjahn F; Schmidt RE; Gessner JE
Eur J Immunol; 2009 Dec; 39(12):3343-56. PubMed ID: 19795417
[TBL] [Abstract][Full Text] [Related]
31. Production of virus-specific antiserum corresponding to sequences in the lactate dehydrogenase-elevating virus (LDV) ORF6 protein.
Takahashi-Omoe H; Omoe K; Sakaguchi M; Kameoka Y; Matsushita S; Inada T
Comp Immunol Microbiol Infect Dis; 2004 Jan; 27(1):47-55. PubMed ID: 14656541
[TBL] [Abstract][Full Text] [Related]
32. Lactic dehydrogenase virus (LDV) infection inhibits allergic eosinophil reaction in the airway.
Morimoto M; Ohji T; Iwata H; Hayashi T
Res Vet Sci; 2002 Apr; 72(2):131-6. PubMed ID: 12027593
[TBL] [Abstract][Full Text] [Related]
33. Autoantibodies to cryptic epitopes elicited by infection with lactate dehydrogenase-elevating virus.
Gómez KA; Coutelier J; Mathieu PA; Lustig L; Retegui LA
Scand J Immunol; 2000 May; 51(5):447-53. PubMed ID: 10792835
[TBL] [Abstract][Full Text] [Related]
34. Exacerbation of autoantibody-mediated thrombocytopenic purpura by infection with mouse viruses.
Musaji A; Cormont F; Thirion G; Cambiaso CL; Coutelier JP
Blood; 2004 Oct; 104(7):2102-6. PubMed ID: 15205264
[TBL] [Abstract][Full Text] [Related]
35. Two-step mechanism of virus-induced autoimmune hemolytic anemia.
Coutelier JP; Detalle L; Musaji A; Meite M; Izui S
Ann N Y Acad Sci; 2007 Aug; 1109():151-7. PubMed ID: 17785301
[TBL] [Abstract][Full Text] [Related]
36. Changes in the specificity of antibodies in mice infected with lactate dehydrogenase-elevating virus.
Gómez KA; Coutelier JP; Retegui LA
Scand J Immunol; 1997 Aug; 46(2):168-74. PubMed ID: 9583997
[TBL] [Abstract][Full Text] [Related]
37. Neuropathogenicity and sensitivity to antibody neutralization of lactate dehydrogenase-elevating virus are determined by polylactosaminoglycan chains on the primary envelope glycoprotein.
Chen Z; Li K; Plagemann PG
Virology; 2000 Jan; 266(1):88-98. PubMed ID: 10612663
[TBL] [Abstract][Full Text] [Related]
38. GM-CSF, via PU.1, regulates alveolar macrophage Fcgamma R-mediated phagocytosis and the IL-18/IFN-gamma -mediated molecular connection between innate and adaptive immunity in the lung.
Berclaz PY; Shibata Y; Whitsett JA; Trapnell BC
Blood; 2002 Dec; 100(12):4193-200. PubMed ID: 12393686
[TBL] [Abstract][Full Text] [Related]
39. Cytokine regulation of lactate dehydrogenase-elevating virus: inhibition of viral replication by interferon-gamma.
Cafruny WA; Bradley SE; Broen JJ; Wong GH
Antiviral Res; 1994 Apr; 23(3-4):191-201. PubMed ID: 8042859
[TBL] [Abstract][Full Text] [Related]
40. Critical role of galectin-3 in phagocytosis by macrophages.
Sano H; Hsu DK; Apgar JR; Yu L; Sharma BB; Kuwabara I; Izui S; Liu FT
J Clin Invest; 2003 Aug; 112(3):389-97. PubMed ID: 12897206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
